Ampio Pharmaceuticals, Inc.
OTC: AMPE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael A. Martino
- Employees
- 6
- Headquarters
- Englewood, United States
- IPO year
- 2010
- Market cap
- $207.9K
- Website
- https://www.ampiopharma.com
Loading AMPE…
Loading profile data…Frequently asked questions about AMPE
What does Ampio Pharmaceuticals, Inc. (AMPE) do?
Ampio Pharmaceuticals, Inc., headquartered in Englewood, Colorado, is a biopharmaceutical firm dedicated to advancing immunomodulatory therapeutics primarily for the management of osteoarthritis pain across the United States. Their developmental pipeline currently features several compounds: AP-013, an intra-articular injection, is undergoing Ph...
Where does AMPE trade?
Ampio Pharmaceuticals, Inc. (AMPE) trades on the Other OTC.
What sector is AMPE in?
Ampio Pharmaceuticals, Inc. (AMPE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ampio Pharmaceuticals, Inc.?
Michael A. Martino is the chief executive officer of Ampio Pharmaceuticals, Inc. (AMPE).
Where is Ampio Pharmaceuticals, Inc. headquartered?
Ampio Pharmaceuticals, Inc. is headquartered in United States.
Does AMPE pay a dividend?
Ampio Pharmaceuticals, Inc. (AMPE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMPE go public?
Ampio Pharmaceuticals, Inc. (AMPE) completed its initial public offering in 2010.